Bain Capital Public Equity Management, LLC - Q2 2017 holdings

$1.66 Billion is the total value of Bain Capital Public Equity Management, LLC's 55 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 93.1% .

 Value Shares↓ Weighting
HON NewHONEYWELL INTL INC$151,186,0001,134,265
+100.0%
9.10%
AABA NewALTABA INC$142,023,0002,606,887
+100.0%
8.55%
NOC BuyNORTHROP GRUMMAN CORP$107,881,000
+32.5%
420,243
+22.8%
6.49%
+12.6%
PNR BuyPENTAIR PLC$87,918,000
+77.4%
1,321,273
+67.3%
5.29%
+50.7%
JCI NewJOHNSON CTLS INTL PLC$76,382,0001,761,567
+100.0%
4.60%
GDDY BuyGODADDY INCcl a$71,216,000
+58.9%
1,678,837
+42.0%
4.29%
+35.0%
BLL BuyBALL CORP$69,528,000
+48.2%
1,647,202
+160.7%
4.18%
+25.9%
VRTX BuyVERTEX PHARMACEUTICALS INC$58,056,000
+90.2%
450,498
+61.4%
3.49%
+61.7%
JACK NewJACK IN THE BOX INC$54,752,000555,854
+100.0%
3.30%
FB BuyFACEBOOK INCcl a$54,632,000
+14.4%
361,846
+7.6%
3.29%
-2.8%
CTXS BuyCITRIX SYS INC$53,443,000
-1.3%
671,559
+3.4%
3.22%
-16.1%
NXPI BuyNXP SEMICONDUCTORS N V$52,208,000
+161.7%
477,001
+147.4%
3.14%
+122.4%
BAC SellBANK AMER CORP$51,754,000
-6.0%
2,133,306
-8.6%
3.12%
-20.1%
Q SellQUINTILES IMS HOLDINGS INC$48,031,000
-2.5%
536,657
-12.2%
2.89%
-17.1%
NVS NewNOVARTIS A Gspon adr$45,845,000549,240
+100.0%
2.76%
DOX SellAMDOCS LTD$45,238,000
-8.0%
701,797
-13.0%
2.72%
-21.8%
RGNX SellREGENXBIO INC$34,759,000
-4.9%
1,759,961
-7.0%
2.09%
-19.2%
FCEA NewFOREST CITY RLTY TR INC$34,541,0001,429,080
+100.0%
2.08%
MULE BuyMULESOFT INCcl a$32,858,000
+92.1%
1,317,471
+87.4%
1.98%
+63.3%
PBYI BuyPUMA BIOTECHNOLOGY INC$29,628,000
+818.7%
338,994
+291.0%
1.78%
+682.0%
DLTR NewDOLLAR TREE INC$27,978,000400,150
+100.0%
1.68%
AVXS BuyAVEXIS INC$26,220,000
+185.0%
319,138
+163.8%
1.58%
+142.4%
IVZ NewINVESCO LTD$24,946,000708,900
+100.0%
1.50%
COL NewROCKWELL COLLINS INC$23,943,000227,851
+100.0%
1.44%
AET NewAETNA INC NEW$22,453,000147,881
+100.0%
1.35%
ETFC NewE TRADE FINANCIAL COR$22,016,000578,900
+100.0%
1.32%
RDUS SellRADIUS HEALTH INC$20,690,000
-53.7%
457,437
-60.4%
1.24%
-60.7%
DG NewDOLLAR GEN CORP NEW$20,589,000285,600
+100.0%
1.24%
HLT SellHILTON WORLDWIDE HLDGS INC$16,222,000
-69.3%
262,280
-71.0%
0.98%
-73.9%
ULTI NewULTIMATE SOFTWARE GROUP INC$14,984,00071,330
+100.0%
0.90%
CLVS BuyCLOVIS ONCOLOGY INC$13,160,000
+350.4%
140,558
+206.2%
0.79%
+282.6%
CLDR NewCLOUDERA INC$13,106,000886,813
+100.0%
0.79%
QQQ NewPOWERSHARES QQQ TRUSTput$11,401,00024,800
+100.0%
0.69%
CAR BuyAVIS BUDGET GROUP$10,583,000
-0.1%
388,092
+8.4%
0.64%
-15.1%
VYGR SellVOYAGER THERAPEUTICS INC$10,541,000
-47.4%
1,176,470
-22.3%
0.63%
-55.4%
ANTM SellANTHEM INC$9,473,000
-69.9%
50,354
-73.5%
0.57%
-74.4%
GILD SellGILEAD SCIENCES IN$8,478,000
-2.2%
119,780
-6.1%
0.51%
-16.9%
AFMD  AFFIMED N V$6,578,000
-10.9%
3,209,0130.0%0.40%
-24.3%
ALKS BuyALKERMES PLC$6,341,000
-88.2%
109,380
+19.4%
0.38%
-89.9%
VSAT SellVIASAT INC$6,067,000
-87.4%
91,640
-87.9%
0.36%
-89.3%
GLPG BuyGALAPAGOS NVspon adr$5,443,000
+15.7%
71,136
+30.3%
0.33%
-1.5%
CUDA NewBARRACUDA NETWORKS INC$5,145,000223,100
+100.0%
0.31%
DVAX NewDYNAVAX TECHNOLOGIES CORP$4,741,000491,300
+100.0%
0.28%
EPZM NewEPIZYME INC$4,331,000286,850
+100.0%
0.26%
EBSB NewMERIDIAN BANCORP INC MD$4,056,000240,000
+100.0%
0.24%
DKS NewDICKS SPORTING GOODS$3,820,00095,900
+100.0%
0.23%
IMDZ BuyIMMUNE DESIGN CORP$3,797,000
+607.1%
389,400
+393.1%
0.23%
+502.6%
VRTX NewVERTEX PHARMACEUTICALS INCcall$3,303,0002,521
+100.0%
0.20%
IWM BuyISHARES TRput$2,175,000
-17.8%
12,500
+30.2%
0.13%
-29.9%
TSRO NewTESARO INC$2,028,00014,500
+100.0%
0.12%
ARD  ARDAGH GROUP S Acl a$1,583,000
+3.0%
70,0000.0%0.10%
-12.8%
AZN NewASTRAZENECA PLCcall$1,450,00010,000
+100.0%
0.09%
PTI NewPROTEOSTASIS THERAPEUTICS IN$1,233,000263,498
+100.0%
0.07%
AZN NewASTRAZENECA PLCput$875,00010,000
+100.0%
0.05%
JWN ExitNORDSTROM INCcall$0-7,500
-100.0%
0.00%
MRK ExitMERCK & CO INCput$0-12,300
-100.0%
-0.13%
GLOB ExitGLOBANT S A$0-134,900
-100.0%
-0.35%
TFX ExitTELEFLEX INC$0-25,800
-100.0%
-0.35%
MDT ExitMEDTRONIC PLC$0-62,800
-100.0%
-0.36%
SBAC ExitSBA COMMUNICATIONS CORP NEWcl a$0-43,491
-100.0%
-0.37%
IBKC ExitIBERIABANK CORP$0-74,190
-100.0%
-0.42%
XRX ExitXEROX CORP$0-892,700
-100.0%
-0.46%
EVHC ExitENVISION HEALTHCARE CORP$0-111,887
-100.0%
-0.49%
BMY ExitBRISTOL MYERS SQUIBB COput$0-12,000
-100.0%
-0.49%
SCG ExitSCANA CORP NEW$0-107,005
-100.0%
-0.50%
NKE ExitNIKE INCcl b$0-146,900
-100.0%
-0.58%
AZN ExitASTRAZENECA PLCsponsored adr$0-40,000
-100.0%
-0.63%
ARRS ExitARRIS INTL INC$0-348,000
-100.0%
-0.65%
MRK ExitMERCK & CO INC$0-149,400
-100.0%
-0.67%
ONCE ExitSPARK THERAPEUTICS INC$0-228,517
-100.0%
-0.86%
MGP ExitMGM GROWTH PPTYS LLC$0-451,387
-100.0%
-0.86%
VIAV ExitVIAVI SOLUTIONS INC$0-1,210,000
-100.0%
-0.92%
DOV ExitDOVER CORP$0-184,555
-100.0%
-1.05%
GPN ExitGLOBAL PMTS INC$0-224,922
-100.0%
-1.28%
MRK ExitMERCK & CO INCcall$0-41,000
-100.0%
-1.34%
RTN ExitRAYTHEON CO$0-130,750
-100.0%
-1.41%
HUM ExitHUMANA INC$0-99,753
-100.0%
-1.46%
LSXMK ExitLIBERTY MEDIA CORP DELAWARE$0-815,067
-100.0%
-2.24%
VOYA ExitVOYA FINL INC$0-893,863
-100.0%
-2.40%
CMCSA ExitCOMCAST CORP NEWcl a$0-1,150,336
-100.0%
-3.06%
LLL ExitL3 TECHNOLOGIES INC$0-285,008
-100.0%
-3.34%
PK ExitPARK HOTELS RESORTS INC$0-2,599,117
-100.0%
-4.72%
GD ExitGENERAL DYNAMICS CORP$0-450,496
-100.0%
-5.97%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Brookside Capital Investors, L.P. #1
  • Brookside Capital Partners Fund, L.P. #2
  • Brookside Capital Investors II, L.P. #3
  • Brookside Capital Trading Fund, L.P. #4
  • Brookside Capital Investors III, L.P. #5
  • Brookside Capital Partners Fund III, L.P. #6
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CITRIX SYS INC18Q3 20186.7%
QUINTILES TRANSNATIO HLDGS I18Q3 20173.5%
AFFIMED N V16Q1 20191.0%
BALL CORP13Q1 20197.2%
RADIUS HEALTH INC13Q2 20178.4%
TRANSDIGM GROUP INC11Q2 201610.1%
ULTA SALON COSMETCS & FRAG I11Q4 20155.4%
VIASAT INC11Q2 20177.5%
AETNA INC NEW11Q2 20174.1%
GODADDY INC10Q1 20195.7%

View Bain Capital Public Equity Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bain Capital Public Equity Management, LLC Q2 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Affimed N.V.February 14, 20192,362,8133.8%
IMMUNE DESIGN CORP.February 14, 2019892,0611.8%
REVA Medical, Inc.February 14, 2019296,502,2207.2%
MULESOFT, INCFebruary 14, 20181,404,0251.9%
CONCERT PHARMACEUTICALS, INC.February 28, 20141,147,8336.7%
IDENIX PHARMACEUTICALS INCFebruary 12, 201413,115,8589.8%
NORTHSTAR REALTY FINANCE CORP.February 12, 20147,657,7812.6%
PORTOLA PHARMACEUTICALS INCFebruary 12, 2014400,0001.0%
Dicerna Pharmaceuticals IncFebruary 10, 20141,337,0008.0%
RingCentral IncFebruary 07, 2014471,0735.5%

View Bain Capital Public Equity Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
SC 13G/A2019-02-14
SC 13G/A2019-02-14

View Bain Capital Public Equity Management, LLC's complete filings history.

Compare quarters

Export Bain Capital Public Equity Management, LLC's holdings